miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164

Lung cancer is one of the leading causes of cancer-associated mortality. Non-small cell lung carcinoma (NSCLC) accounts for 70–85% of the total cases of lung cancer. Radioresistance frequently develops in NSCLC in the middle and later stages of radiotherapy. We investigated the role of miR-219a-5p i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Tao, Cheng, Shan, Fu, Xiao Na, Feng, Lian Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378263/
https://www.ncbi.nlm.nih.gov/pubmed/32364222
http://dx.doi.org/10.1042/BSR20192795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378263/
https://www.ncbi.nlm.nih.gov/pubmed/32364222
http://dx.doi.org/10.1042/BSR20192795

Ejemplares similares